Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SedOSA: DAW2020 in Obstructive Sleep Apnea
NCT04538755Phase 2Enrolling by invitation
- Sponsor
- Brigham and Women's Hospital
- Start
- Nov 2020
- Primary completion
- May 2025
- Countries
- 1
01
Overview
A Phase 2 trial of DAW2020 in obstructive sleep apnea (OSA), sponsored by Brigham and Women's Hospital. Started Nov 2020; status: enrolling by invitation.
02
Drugs
DAW2020
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT04538755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04538755.